Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Tundra bilberry (Vaccinium uliginosum) contains high concentrations of anthocyanins, polyphenols, and pterostilbene that activate AMPK-mTOR and FOXO3a pathways to reduce oxidative stress and inflammation. These compounds inhibit pro-inflammatory cytokines TNF-α and IL-6 while inducing antioxidant enzymes like superoxide dismutase and catalase.
Reported Benefits (Provisional)
Origin & History
Tundra Bilberry (Vaccinium myrtillus) is a wild berry native to the boreal forests and tundra margins of Northern Europe, Siberia, and Arctic North America. It thrives in cold, acidic soils and is traditionally revered for its potent vision-supporting and adaptogenic properties, making it a vital functional food in harsh environments.
Research Narrative (Provisional)
Scientific studies, including those in PubMed and ScienceDirect, support Tundra Bilberry's efficacy in enhancing retinal health and night vision, primarily due to its anthocyanin content. Research also indicates its potential for cognitive clarity, blood sugar regulation, and vascular integrity.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Anthocyanins (delphinidin, cyanidin, petunidin) - Polyphenols (quercetin, resveratrol, chlorogenic acid) - Vitamin C - Soluble fiber
Reported Mechanism (Provisional)
Tundra bilberry's anthocyanins, quercetin, chlorogenic acid, and pterostilbene activate AMPK-mTOR and FOXO3a autophagy pathways while inducing antioxidant enzymes including superoxide dismutase, catalase, GST, and GSH-Px. These polyphenolic compounds attenuate pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and COX-2 expression while inhibiting nitric oxide production. Triterpenoids like oleanolic and ursolic acid provide additional anti-inflammatory effects through modulation of IFN-γ-induced immune responses.
Clinical Narrative (Provisional)
Human clinical trials specific to tundra bilberry (Vaccinium uliginosum) are lacking, with most evidence derived from related bilberry species or in vitro studies. Related bilberry studies show platelet aggregation inhibition at 480 mg/day for 30-60 days in humans. In vitro antioxidant activity demonstrates DPPH scavenging at EC50 of 9.24 ± 0.22 μg/mL and ABTS at 12.70 ± 0.11 μg/mL. Current evidence strength is limited due to absence of controlled human trials for this specific species.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.